Navigation Links
AIDS Action Observes HIV Vaccine Awareness Day: Reason to Hope
Date:5/18/2009

WASHINGTON, May 18 /PRNewswire-USNewswire/ -- Every nine and a half minutes someone in the United States is infected with HIV. The Centers for Disease Control and Prevention (CDC) estimates that approximately 56,300 individuals became infected with HIV in 2006 alone. There are over 1.1 million people living with the virus in the United States. It is a disease that impacts minority and poor communities disproportionately: African-Americans are seven times more likely to contract HIV, while the rate of infection among Hispanics is three times that of whites. Amidst this tragic reality, the ongoing search for an HIV vaccine gives us reason to hope. The HIV vaccine research field continues to advance, and 2009 marks a year of promise. Today, on May 18th, HIV Vaccine Awareness Day, AIDS Action urges everyone to help end the AIDS epidemic by supporting HIV vaccine research. We also thank the numerous volunteers, community educators, scientists and advocates for their efforts to support HIV vaccine research.

The best long term hope for controlling the AIDS epidemic here and abroad is the development of safe, effective and affordable HIV vaccines. Historically, vaccines have been the most powerful weapon against diseases like polio, measles and Hepatitis B. In fact, no major viral epidemic has been defeated without one. HIV vaccine research is part of a robust HIV prevention research agenda, and integral to a sustainable comprehensive response to the epidemic.

While researchers have not yet found a vaccine, there are reasons to be hopeful. Several large scale efficacy trials in humans have already been completed. While their results did not yield an effective vaccine, they prompted innovative researchers to focus on basic science, leading to greater insight into human immunology. Using the lessons of the past, scientists are currently designing better clinical trials. And, there are promising candidates in the HIV vaccine pipeline. Results in the largest vaccine trial of 16,000 study participants in Thailand are expected in late 2009. There are several other candidates in clinical trials, and a new trial in the United States will soon begin. In this past year alone, six novel approaches being tested in monkeys have shown unprecedentedly positive initial findings. AIDS Action believes the horizon is bright.

This HIV Vaccine Awareness Day, we must remind ourselves that a life-saving HIV vaccine is possible. To be sure, it will require our best scientific minds. It will also rely on commitment from our political leaders and global investment, as well as support from ordinary citizens. AIDS Action is committed to advocating for continued political commitment and optimizing the environment for HIV vaccine research through education and awareness building. Through its membership network of AIDS service organizations, health departments, health educators and community-based organizations across the country, AIDS Action is working to establish leadership and increase HIV vaccine awareness among key influencers and community and national leaders.

But we can't do it alone. We need your help. Stay informed. Learn about HIV vaccine research efforts, talk about HIV vaccine research with your family and friends, support a trial volunteer, contact your local trial site to become a volunteer or join a community advisory board. We encourage everyone to become involved in HIV Vaccine Awareness Day.

Learn more about events in your area, how you can help, and the facts about HIV vaccine research at http://www.bethegeneration.org/ and http://www.aidsaction.org/.

AIDS Action strives to end the HIV epidemic by advancing public policies that prevent new infections, provide care for people living with HIV and support the search for a cure. AIDS Action serves as the national voice for AIDS service organizations, health departments and a diverse network of community-based organizations across the country that provide services for people living with or affected by HIV infection.


'/>"/>
SOURCE AIDS Action
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mitchell and Jopari Say Green Transaction Initiatives Play Key Role in P&C and Group Health Industry Environmental Best Practices
2. OpenViBE: The first French software program enabling action through thought
3. Physician practice interactions with health plans cost $31 billion a year
4. Dr. Peter J. Capizzi of Stillwater Plastic Surgery Honored in Patient Satisfaction Survey
5. CriticalPoint(TM) Training Rated Excellent in Customer Satisfaction
6. Breast Cancer Action Sues to End Gene Patenting
7. Shareholder Class Action Filed Against Sequenom, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
8. A Global Call to Action From HIV Co-Discoverers Robert Gallo and Luc Montagnier
9. AIDS Action Welcomes Presidents Budget Increases Yet Expresses Distress With Failure to End Federal Ban on Syringe Exchange Funding
10. Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA
11. Polls Show Americans Concerned About Swine Flu, Taking Actions to Protect Themselves
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... Aliso Viejo, California (PRWEB) , ... June 25, 2016 , ... ... preset to fit their specific project," said Christina Austin - CEO of Pixel Film ... all fully customizable and all within Final Cut Pro X . Simply select ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... 2016 , ... People across the U.S. are sharpening their pencils and honing ... contest in which patients and their families pay tribute to a genetic counselor by ... Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas ... Brasil as the company,s second affiliate in Latin America . ... ... of Astellas Farma Colombia ... ...
(Date:6/23/2016)... , June 23, 2016  Experian ... integrating and transforming the patient payment and ... several innovative new products and services that ... its revenue cycle offerings. These award-winning solutions ... efficient workflows, remain compliant in an ever-changing ...
Breaking Medicine Technology: